Publicacións en colaboración con investigadores/as de Corporació Sanitària Parc Taulí (14)

2023

  1. Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference and Adherence, Vol. 17, pp. 1431-1439

2020

  1. Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on

    Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492

  2. Factors Associated With Extrapulmonary Tuberculosis in Spain and Its Distribution in Immigrant Population

    Open Respiratory Archives, Vol. 2, Núm. 3, pp. 119-126

2018

  1. QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial

    Clinical Infectious Diseases, Vol. 66, Núm. 3, pp. 396-403

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  2. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

  3. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

2016

  1. Factors associated with fatality during the intensive phase of anti-tuberculosis treatment

    PLoS ONE, Vol. 11, Núm. 8

  2. Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment

    Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268

2012

  1. A predictive scoring instrument for tuberculosis lost to follow-up outcome

    Respiratory Research, Vol. 13

  2. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

2009

  1. Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycoside-modifying enzyme gene ant(4′)-Ia and the efflux pump genes msrA/msrB

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 1, pp. 21-31

2008

  1. Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain

    Emerging Infectious Diseases, Vol. 14, Núm. 8, pp. 1259-1262

2004

  1. Antibiotic resistance in 3113 blood isolates of Staphylococcus aureus in 40 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000-2002)

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 6, pp. 1033-1038